SPCX Fades Toward Its $150 Open as the MSCI Bid Stays Two Weeks Out

The Bid That Isn't Here Yet

The bull case for owning SpaceX at a $1.77 trillion valuation has a structural crutch: forced index buying. The problem is the timing. MSCI confirmed it will fast-track SPCX into its Global Standard Indexes under its large-IPO rule, but that inclusion lands roughly ten trading days after the June 12 listing — call it the end of June — and the passive funds tracking those benchmarks hold around $5.79 trillion. That is a real, mechanical bid. It just isn't here yet, with demand from funds tracking the Nasdaq 100, Russell and FTSE benchmarks potentially following behind it.

And one of the gatekeepers already said no: S&P rejected SpaceX on profitability grounds, the same wall that keeps money-losing names out of the S&P 500. So the passive demand bulls are underwriting is both delayed by two weeks and smaller than a clean sweep of every major index would imply. In the gap, the perp is down 7.53% over 21 hours to $164.1, drifting back toward its $150 listing open with no index put underneath to lean on.

What's Actually Pressuring the Tape

Strip away the index narrative and the fade is straightforward valuation digestion. SpaceX priced at $135, opened at $150 and closed up about 19% near $161 on Friday, briefly carrying a market cap above $2 trillion intraday. That print has to be defended on fundamentals now that the allocation scramble is over — and the fundamentals are the bear case.

In the first quarter SpaceX posted a $4.30 billion net loss on $4.70 billion of revenue, versus a $528 million loss a year earlier, and full-year 2025 was a $4.9 billion loss on $18.7 billion of revenue against $6.6 billion of adjusted EBITDA. The engine underneath is Starlink — roughly $11.4 billion of 2025 revenue, about 61% of the total, and the company's only profitable segment — effectively bankrolling Starship and xAI losses. That is a defensible long-term story attached to a brutal near-term multiple. CFRA opened coverage with a rare Sell and a $115 target, below the IPO price; Oppenheimer started at Outperform with $190; Morningstar pegs fair value at well under half the listing mark. With targets that far apart there is no consensus to anchor on, so every tick lower is just the market voting — and right now CFRA's number is winning.

The Setup Into Late June

The constructive read is that this is an orderly bleed, not a break. At $164.1 the perp is still comfortably above the $135 IPO price and the $150 open, the $1.35 billion of 24-hour volume on the Hyperliquid market shows the digestion is happening on real two-way flow, and the broader space complex that sold off hard on the debut — Redwire, AST SpaceMobile and Rocket Lab all down around 10% or more as capital rotated into the listing — leaves SPCX as the cleanest single expression of the trade.

The question that matters is what shape the stock is in when the MSCI bid finally arrives. If the premium keeps bleeding, late June becomes a forced buyer stepping into a name that has already given back most of its listing pop — a setup that can snap higher. If the fade stalls here, the index add lands into strength and the late shorts get squeezed. Either way, the next two weeks are price discovery without the passive bid, and that is exactly where a freshly public name carrying a multibillion-dollar quarterly loss is most exposed.